The FDA again adds more drugs to its valsartan recall list

The FDA added more products to its Valsartan recall list

Story highlights

  • The FDA added an additional lot of RemedyRepack to its recall list for drugs containing valsartan
  • Imports to the US from the Chinese company that manufactured the valsartan ingredient have been stopped

(CNN)The US Food and Drug Administration again added to its list of products that are included in the recall of drugs containing valsartan, a generic ingredient that helps people with high blood pressure and heart failure. That ingredient in the recalled drugs was tainted with a possible carcinogen.

The FDA testing of these products determined that an additional lot of brands sold under the name RemedyRepack needed to be added to the recall list.
Several pills that contain valsartan have been under a voluntary recall since July. The drugs were tainted with N-nitrosodimethylamine, or NDMA, an impurity that is considered a possible carcinogen by the US Environmental Protection Agency. It's an organic chemical used to make liquid rocket fuel and a byproduct from manufacturing some pesticides and processing fish. NDMA can be unintentionally introduced into manufacturing through certain chemical reactions.